Revel-Vilk Shoshana
Pediatric Hematology/Oncology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Acta Haematol. 2006;115(3-4):201-6. doi: 10.1159/000090936.
Central venous lines are used in critically ill children and in children with chronic conditions for the administration of intravenous therapy, such as fluids, medications, total parenteral nutrition and blood products. Although the use of central venous lines has greatly improved the quality of care in these children, these catheters may cause serious mechanical, infectious and thrombotic complications. The reported frequency of catheter thrombosis in children is low as 5% in studies including only symptomatic cases and high as 50% in studies where patients are systematically screened for catheter-related thrombosis. The risk factors for catheter-related thrombosis in children are associated with the methods used for catheter insertion and with individual patient characteristics, underlying diagnosis and treatment. The management of catheter-related thrombosis is largely dependent on the requirement of the catheter. If no longer required or nonfunctioning the catheter should be removed. If access is still required and the catheter is functioning, treatment with anticoagulation is recommended in the absence of contraindications. The management of radiographically detected asymptomatic thrombosis in children is less clear. Clinical studies of prophylaxis for catheter-related thrombosis are inconclusive and no definitive recommendations for prophylaxis in adults or in children with central venous thrombosis can be made. Properly designed studies are needed to assess the role of prophylactic anticoagulation for preventing catheter-related thrombosis.
中心静脉导管用于危重症儿童和患有慢性病的儿童,以进行静脉治疗,如输液、给药、全胃肠外营养和血液制品输注。尽管使用中心静脉导管极大地改善了这些儿童的护理质量,但这些导管可能会引起严重的机械性、感染性和血栓性并发症。在仅纳入有症状病例的研究中,儿童导管血栓形成的报告发生率低至5%,而在对患者进行导管相关血栓系统筛查的研究中,该发生率高达50%。儿童导管相关血栓形成的危险因素与导管插入方法以及个体患者特征、基础诊断和治疗有关。导管相关血栓的处理很大程度上取决于导管的需求情况。如果不再需要或导管失去功能,应将其拔除。如果仍需要通路且导管功能正常,在无禁忌证的情况下建议进行抗凝治疗。对于影像学检查发现的儿童无症状血栓的处理尚不清楚。关于预防导管相关血栓形成的临床研究尚无定论,无法对成人或有中心静脉血栓形成的儿童给出明确的预防建议。需要进行设计合理的研究来评估预防性抗凝在预防导管相关血栓形成中的作用。